Clinical Trials for Infertility
94 infertility trials indexed, 40 currently recruiting. Updated daily from ClinicalTrials.gov.
Understanding Infertility
Infertility is defined as the inability to conceive a child after one year of regular, unprotected sexual intercourse. It involves complex biological and pathological factors affecting both men and women. In women, infertility can result from ovulation disorders, fallopian tube damage, or uterine abnormalities. In men, it often stems from issues with sperm production or function. Diagnosis typically involves medical history review, physical exams, hormone testing, and imaging studies such as ultrasound. Semen analysis is a common diagnostic tool for male infertility.
Common symptoms of infertility include the inability to conceive despite regular intercourse and irregular menstrual cycles in women. The typical age of onset varies, but infertility often becomes a concern for couples in their late 20s to early 30s. Women over 35 face increased risks due to declining egg quality and quantity. Both men and women can be affected, with risk factors including smoking, excessive alcohol use, obesity, certain medical conditions, and environmental exposures. Lifestyle factors and underlying health issues can also contribute to difficulties in conceiving.
Infertility matters medically and socially because it affects an estimated 10 to 15 percent of couples worldwide. This condition can lead to emotional distress, relationship strain, and significant financial costs. For example, the economic burden of infertility treatments in the United States alone reaches billions of dollars annually. Medically, untreated infertility can sometimes indicate other health problems such as hormonal imbalances or infections. Socially, infertility may impact family planning decisions and cultural expectations related to parenthood.
The Infertility Treatment Landscape
The first-line standard of care for infertility often begins with lifestyle modifications and basic fertility evaluations. For women, treatments may include ovulation induction using medications like clomiphene citrate to stimulate egg release. In men, improving sperm health through lifestyle changes or treating infections is common. Couples may also receive counseling and guidance on timing intercourse to increase chances of conception. These initial steps are usually followed by more advanced interventions if conception does not occur within six to twelve months.
Second-line treatments include assisted reproductive technologies such as intrauterine insemination (IUI) and in vitro fertilization (IVF). Drug classes used in these treatments include gonadotropins to stimulate the ovaries and medications to support the uterine lining. Established drugs for ovulation induction include follicle-stimulating hormone (FSH) and human chorionic gonadotropin (hCG). Third-line options may involve surgical interventions to correct anatomical problems or address severe male factor infertility. These treatments are more invasive and costly but can increase the chances of pregnancy in difficult cases.
Despite available treatments, gaps remain in managing infertility effectively. Some patients respond poorly to standard therapies due to resistant ovulation or poor sperm quality. Side effects from hormonal drugs can include mood swings, bloating, and ovarian hyperstimulation syndrome. Additionally, treatments like IVF may not be accessible or affordable for all patients. Research is focused on improving drug efficacy, reducing side effects, and developing personalized approaches to address subgroups that currently have limited options.
Why Clinical Trials Matter for Infertility
Clinical trials offer patients access to new treatments that are not yet widely available. Participation provides closer medical monitoring and the opportunity to contribute to scientific knowledge that may benefit others. According to ClinicalTrials.gov, there are currently 94 infertility clinical trials indexed, with 40 actively recruiting participants. These studies explore novel drugs, improved protocols, and alternative therapies aimed at increasing pregnancy rates and reducing treatment burdens.
There are risks involved with clinical trials that patients should consider. Some treatments may not prove effective, and participants might receive a placebo instead of active medication in randomized studies. Additional clinic visits and tests are often required, which can be time-consuming. Side effects from experimental treatments may be unknown or more severe than standard therapies. Patients should discuss these factors carefully with their healthcare providers before enrolling.
The infertility clinical trial landscape includes a variety of sponsors such as academic institutions, pharmaceutical companies, and cooperative research groups. These organizations collaborate to design studies that address unanswered questions in infertility care. ClinicalTrials.gov serves as a central registry that helps patients and doctors find relevant trials. It provides detailed information about study goals, eligibility criteria, and locations, making it easier to connect with ongoing research opportunities.
What to Look for in a Infertility Clinical Trial
Clinical trials are categorized into four phases to test new treatments or interventions. Phase 1 trials focus on safety and dosage, usually involving a small number of participants. Phase 2 trials evaluate effectiveness and side effects in a larger group. Phase 3 trials compare the new treatment to current standard treatments to confirm benefits and monitor adverse reactions. Phase 4 trials occur after a treatment is approved, gathering additional information on long-term effects and effectiveness in diverse populations. For infertility trials, the distribution is as follows: 42 trials have no specified phase, 10 are Phase 4, 6 are Phase 3, and 4 are Phase 1.
Inclusion criteria for infertility clinical trials often include specific age ranges, typically women aged 18 to 40 years, as fertility potential decreases with age. Prior treatments may also be considered; some trials require participants to have tried certain fertility therapies without success. Biomarkers like hormone levels (e.g., FSH or AMH) and ultrasound findings can be used to select participants with particular ovarian reserve or uterine conditions. Additionally, staging of infertility causes, such as endometriosis severity or tubal blockage, may be required. Duration of infertility, often defined as the length of time trying to conceive, is commonly used to ensure participants have a consistent diagnosis.
Exclusion criteria help protect participants and ensure clear study results. Patients with significant comorbidities like uncontrolled diabetes or heart disease are often excluded because these conditions can affect fertility or treatment safety. Drug interactions are another concern; participants taking medications that might interfere with the trial drug or procedure are typically not eligible. Safety thresholds, such as abnormal liver or kidney function tests, are used to avoid risks during the trial. Pregnant women or those breastfeeding are generally excluded to prevent harm to the fetus or infant.
From a patient perspective, practical considerations are important before joining a trial. The trial duration can range from a few weeks to several months, depending on the treatment and follow-up needed. Visit schedules may require frequent clinic appointments for monitoring, blood tests, or ultrasounds. Travel to the trial site can be a burden if it is far from home. Patients should ask the research team key questions: What are the possible risks and benefits? How many visits are required and what will they involve? Is there any cost to participate or compensation offered? What happens if I decide to leave the trial early?
Primary Sources and Further Reading
If you want to learn more about infertility and clinical trials, it is important to consult reliable sources. These websites provide trustworthy information on infertility causes, treatments, and ongoing research. They also offer guidance on how to participate in clinical trials safely and effectively.
- MedlinePlus: Infertility
- ClinicalTrials.gov: Infertility Trials
- National Institute of Child Health and Human Development (NICHD)
- CDC: Infertility
Latest Research and Emerging Treatments for Infertility (2026)
Infertility research continues to explore ways to improve outcomes for patients undergoing assisted reproductive technologies (ART). One ongoing Phase 3 trial compares embryo transfer timing in IVF patients with few embryos, testing cleavage-stage versus blastocyst-stage transfer (NCT06746129). This study aims to determine which timing may increase the chance of pregnancy for people with limited embryos. For patients, this could mean more personalized IVF protocols that better match their embryo availability and improve their chances of success.
New drugs for infertility are also being studied to address hormonal causes of infertility. A trial in Japan is evaluating the safety and efficacy of a combined hormone treatment using follitropin alfa and lutropin alfa compared to human menopausal gonadotropin (hMG) in patients with luteinizing hormone (LH) and follicle-stimulating hormone (FSH) deficiencies (NCT07340827). These hormones stimulate the ovaries to develop follicles, which are essential for ovulation and conception. Early data suggests this combination could offer an alternative infertility treatment for people with specific hormone deficiencies.
Another Phase 3 trial tests the use of human menopausal gonadotropin injections to improve live birth rates in women undergoing frozen embryo transfer cycles (NCT07216742). hMG contains hormones that encourage the growth of ovarian follicles, supporting egg development. Additionally, research on vaginal micronized progesterone doses is underway to find the safest and most effective dose to support pregnancy after frozen embryo transfer (NCT05899010). For patients, these studies may lead to new infertility treatments in 2026 that better support embryo implantation and pregnancy maintenance, offering more options for those facing infertility challenges.
Frequently asked questions about Infertility trials
How do I find Infertility clinical trials?
The authoritative source for Infertility clinical trials is ClinicalTrials.gov, maintained by the U.S. National Library of Medicine. 94 infertility studies are currently indexed. You can search by entering "infertility" as the condition, then filter by recruiting status, phase, and location. TrialsAlert scans ClinicalTrials.gov daily for new infertility trials and delivers a plain-language briefing every Friday explaining what changed.
What phase are most Infertility trials in?
Across the 94 infertility trials TrialsAlert indexes, the most common phase is Phase 4. Early-phase studies (Phase 1 and Phase 2) test safety and initial efficacy. Phase 3 trials compare a candidate treatment against the current standard of care in larger populations and generate the evidence regulators use to approve new therapies.
How many Infertility clinical trials are currently recruiting?
As of the latest scan, 40 infertility trials have a "Recruiting" status on ClinicalTrials.gov, out of 94 total indexed. The recruiting figure changes daily as studies open, fill enrollment, and close. TrialsAlert subscribers are notified when a new recruiting infertility trial matches their tracked condition.
Stay informed about infertility research
Get a weekly briefing with the trials that matter most.